Skip to main content

Table 5 Documented complication during hospitalization after adjusting for baseline covariates

From: Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry

Variables

Steroids

IL6-RAs

Both

p

Na

804.1

582.4

689.6

 

None

35 (4.3)

40 (6.8)

16 (2.3)

0.30

Acute cardiac injury

63 (7.9)

56 (9.6)

33 (4.8)

0.32

Acute kidney injury

292 (36.4)

280 (48.1)

277 (40.2)

0.15

Cardiac arrest

155 (19.3)

84 (14.4)

114 (16.5)

0.52

Cardiac arrhythmia new onset

101 (12.6)

67 (11.4)

66 (9.6)

0.72

Coagulation disorder disseminated intravascular coagulation

34 (4.3)

59 (10.0)

50 (7.3)

0.23

Deep vein thrombosis

51 (6.3)

59 (10.1)

68 ( 9.9)

0.34

Empyema

3 (0.3)

5 (0.9)

5 (0.7)

0.70

High troponin level

97 (12.1)

57 (9.8)

134 (19.4)

0.04

Liver dysfunction/acute liver failure

118 (14.6)

139 (23.9)

82 (11.9)

0.04

Lung abscesses

3 (0.3)

0 (0)

5 (0.7)

0.45

Myocarditis

8 (1.0)

7 (1.3)

0 (0)

0.28

Pneumothorax

54 (6.8)

35 (6.0)

30 (4.4)

0.64

Causative microbiology and rate of secondary infections

 Respiratory viral panel (RVP) PCR positiveb

1 (0.2)

2 (1.2)

0 (0)

0.72

 Bacterial pneumonia

192 (23.9)

173 (29.7)

197 (28.5)

0.46

 Cytomegalovirus PCR positive

2 (0.3)

0 (0)

1 (0.9)

0.40

 Legionella urine Ag positive

0 (0)

1 (0.6)

0 (0)

0.32

 Blood cultures positivec

93 (21.9)

27 (17.2)

17 (19.3)

0.44

 Hospital day(s) positive blood cultures performed, median [IQR]

7 [0.25; 14]

14 [1; 22]

10 [0.75; 13]

0.14

 Sputum culture positived

167 (50.6)

65 (53.3)

34 (45.9)

0.61

 Hospital day(s) positive sputum culture performed, median [IQR]

4 [1; 11]

5 [1.5; 9]

5 [1; 13.5]

0.87

 Urine culture positivee

74 (29.2)

23 (20.2)

11 (19.6)

0.10

  1. Data presented as n (%) unless otherwise specified
  2. IL6-RAs interleukin-6 receptor antagonists
  3. aEach individual gets its own weight that is used for further analysis. Multiplication by these weights can usually results in decimals
  4. bPerformed in 127 individuals in steroids group, 85 in IL6-RAs group, 33 in combination group
  5. cPerformed in 424 individuals in steroids group, 157 in IL6-RAs group, 88 in combination group
  6. dPerformed in 331 individuals in steroids group, 121 in IL6-RAs group, 74 in combination group
  7. ePerformed in 254 individuals in steroids group, 114 in IL6-RAs group, 56 in combination group
  8. Bold values indicate a significant value at 5% level of significance